Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Earnings Guidance

BrightView Holdings
Regional

BrightView Updates 2025 Outlook, Reaffirms Record EBITDA Despite Revenue Challenges

July 6, 2025July 5, 2025 - by Timothy Alexander

BLUE BELL, PA — BrightView Holdings, Inc. (NYSE: BV), the nation’s largest commercial landscaping services company, announced an update to its fiscal year 2025 financial guidance, highlighting expectations for record …

BrightView Updates 2025 Outlook, Reaffirms Record EBITDA Despite Revenue Challenges Read More

The Chemours Company
Regional

Chemours Updates Second Quarter 2025 Outlook with Strong Gains in Key Segments

June 21, 2025June 20, 2025 - by Timothy Alexander

WILMINGTON, DE — The Chemours Company (NYSE: CC) issued an updated outlook for the second quarter of 2025, highlighting robust performance across several business segments. Notable gains are projected for …

Chemours Updates Second Quarter 2025 Outlook with Strong Gains in Key Segments Read More
Five Below
Regional

Five Below Announces Leadership Transition and Raised Q1 2025 Guidance

May 5, 2025May 5, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Five Below, Inc. (NASDAQ: FIVE) announced key leadership changes and an updated financial outlook for the first quarter of fiscal 2025. Co-founder and Executive Chair Tom Vellios …

Five Below Announces Leadership Transition and Raised Q1 2025 Guidance Read More

InterDigital
Regional

InterDigital Updates Q1 2025 Outlook After Major Smartphone Licensing Deal

March 7, 2025March 6, 2025 - by Timothy Alexander

WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) has significantly raised its first-quarter 2025 guidance after signing a new multi-year, royalty-bearing license agreement with a leading Chinese smartphone manufacturer. This agreement enhances …

InterDigital Updates Q1 2025 Outlook After Major Smartphone Licensing Deal Read More
Nexgel
Regional

NEXGEL Projects Over 100% Revenue Growth for Third Consecutive Year

January 24, 2025January 24, 2025 - by Timothy Alexander

LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) this week issued a letter to its shareholders outlining robust financial guidance for 2024 and 2025, alongside updates on the company’s strategic growth initiatives …

NEXGEL Projects Over 100% Revenue Growth for Third Consecutive Year Read More

Harmony Biosciences
Regional

Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy

January 22, 2025January 21, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced robust preliminary net product revenues for the fourth quarter and full year of 2024, with figures reaching $201 million …

Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy Read More
Optinose
Regional

Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE

January 18, 2025January 16, 2025 - by Timothy Alexander

YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced preliminary unaudited net product revenue of $22.4 million for the fourth quarter of 2024, driven by sustained growth in prescriptions for XHANCE® (fluticasone …

Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE Read More

Neuronetics, Inc
Finance

Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance

January 17, 2025January 15, 2025 - by Timothy Alexander

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has shared its preliminary fourth quarter and full-year revenue figures for 2024, alongside robust guidance and strategic priorities for 2025. The report highlights …

Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance Read More
Cabaletta Bio
Regional

Cabaletta Bio Advances Autoimmune Therapy, Sets Strategic Goals for 2025

January 17, 2025January 15, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has revealed significant progress in its pipeline and operations, underscoring its focus on advancing rese-cel, a cell therapy candidate for autoimmune diseases. …

Cabaletta Bio Advances Autoimmune Therapy, Sets Strategic Goals for 2025 Read More
Arbutus Biopharma
Regional

Arbutus Biopharma Sets Sights on Advancing HBV Cure in 2025

January 17, 2025January 15, 2025 - by Timothy Alexander

WARMINSTER, PA — Arbutus Biopharma Corporation (NASDAQ: ABUS) has unveiled its strategic objectives for 2025 alongside an encouraging financial update, emphasizing progress in its efforts to develop a functional cure for …

Arbutus Biopharma Sets Sights on Advancing HBV Cure in 2025 Read More

Posts pagination

1 2 Next

Trending News

  • Pennsylvania Teen Accused of Recording Heinous Abuse of 9-Month-Old Child

  • Wilmington Man Armed With Butcher Knife Arrested After Violent Newark Hotel Robbery

  • Security Guard Accused of Brutal Assault That Left Man Unconscious Outside Huntingdon Valley Restaurant

  • Vanguard Survey Highlights Emotional and Time-Saving Benefits of Personalized Financial Advice

  • Thieves Target South Heidelberg Shed, Steal Off-Road Vehicles and Power Equipment in Bold Overnight Heist

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Jalvi DeJesus Nunez

Pennsylvania Teen Accused of Recording Heinous Abuse of 9-Month-Old Child

July 12, 2025July 12, 2025

Cortez Crawford

Wilmington Man Armed With Butcher Knife Arrested After Violent Newark Hotel Robbery

July 12, 2025July 12, 2025

Kris Michael Sanchez

Security Guard Accused of Brutal Assault That Left Man Unconscious Outside Huntingdon Valley Restaurant

July 12, 2025July 12, 2025

Copyright © 2025 MyChesCo.